Literature DB >> 22764070

Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement error.

Yunda Huang1, Ying Huang, Zoe Moodie, Sue Li, Steve Self.   

Abstract

In biomedical research such as the development of vaccines for infectious diseases or cancer, study outcomes measured by an assay or device are often collected from multiple sources or laboratories. Measurement error that may vary between laboratories needs to be adjusted for when combining samples across data sources. We incorporate such adjustment in the main study by comparing and combining independent samples from different laboratories via integration of external data, collected on paired samples from the same two laboratories. We propose the following: (i) normalization of individual-level data from two laboratories to the same scale via the expectation of true measurements conditioning on the observed; (ii) comparison of mean assay values between two independent samples in the main study accounting for inter-source measurement error; and (iii) sample size calculations of the paired-sample study so that hypothesis testing error rates are appropriately controlled in the main study comparison. Because the goal is not to estimate the true underlying measurements but to combine data on the same scale, our proposed methods do not require that the true values for the error-prone measurements are known in the external data. Simulation results under a variety of scenarios demonstrate satisfactory finite sample performance of our proposed methods when measurement errors vary. We illustrate our methods using real enzyme-linked immunosorbent spot assay data generated by two HIV vaccine laboratories.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764070      PMCID: PMC4087038          DOI: 10.1002/sim.5446

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Efficient regression calibration for logistic regression in main study/internal validation study designs with an imperfect reference instrument.

Authors:  D Spiegelman; R J Carroll; V Kipnis
Journal:  Stat Med       Date:  2001-01-15       Impact factor: 2.373

2.  Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.

Authors:  Christopher A Todd; Kelli M Greene; Xuesong Yu; Daniel A Ozaki; Hongmei Gao; Yunda Huang; Maggie Wang; Gary Li; Ronald Brown; Blake Wood; M Patricia D'Souza; Peter Gilbert; David C Montefiori; Marcella Sarzotti-Kelsoe
Journal:  J Immunol Methods       Date:  2011-09-22       Impact factor: 2.303

3.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Authors:  M Juliana McElrath; Stephen C De Rosa; Zoe Moodie; Sheri Dubey; Lisa Kierstead; Holly Janes; Olivier D Defawe; Donald K Carter; John Hural; Rama Akondy; Susan P Buchbinder; Michael N Robertson; Devan V Mehrotra; Steven G Self; Lawrence Corey; John W Shiver; Danilo R Casimiro
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

4.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors:  Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

5.  Equivalence of ELISpot assays demonstrated between major HIV network laboratories.

Authors:  Dilbinder K Gill; Yunda Huang; Gail L Levine; Anna Sambor; Donald K Carter; Alicia Sato; Jakub Kopycinski; Peter Hayes; Bridget Hahn; Josephine Birungi; Tony Tarragona-Fiol; Hong Wan; Mark Randles; Andrew Raxworthy Cooper; Aloysius Ssemaganda; Lorna Clark; Pontiano Kaleebu; Steven G Self; Richard Koup; Blake Wood; M Juliana McElrath; Josephine H Cox; John Hural; Jill Gilmour
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

6.  Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.

Authors:  A Mander; C Gouttefangeas; C Ottensmeier; M J P Welters; L Low; S H van der Burg; C M Britten
Journal:  Cancer Immunol Immunother       Date:  2010-01-06       Impact factor: 6.968

7.  The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.

Authors:  C M Britten; C Gouttefangeas; M J P Welters; G Pawelec; S Koch; C Ottensmeier; A Mander; S Walter; A Paschen; J Müller-Berghaus; I Haas; A Mackensen; T Køllgaard; P thor Straten; M Schmitt; K Giannopoulos; R Maier; H Veelken; C Bertinetti; A Konur; C Huber; S Stevanović; T Wölfel; S H van der Burg
Journal:  Cancer Immunol Immunother       Date:  2007-08-25       Impact factor: 6.968

  7 in total
  7 in total

1.  Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America.

Authors:  Zoe Moodie; Michal Juraska; Ying Huang; Yingying Zhuang; Youyi Fong; Lindsay N Carpp; Steven G Self; Laurent Chambonneau; Robert Small; Nicholas Jackson; Fernando Noriega; Peter B Gilbert
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

2.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study.

Authors:  Yunda Huang; Ann Duerr; Nicole Frahm; Lily Zhang; Zoe Moodie; Steve De Rosa; M Juliana McElrath; Peter B Gilbert
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

3.  OPTIK: a database for understanding catchment areas to guide mobilization of cancer center assets.

Authors:  Dinesh Pal Mudaranthakam; Lisa M Harlan-Williams; Roy A Jensen; Hanluen Kuo; Vandita Garimella; Ronald C Chen; Matthew S Mayo; Hope Krebill
Journal:  Database (Oxford)       Date:  2020-01-01       Impact factor: 3.451

4.  Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.

Authors:  Yunda Huang; Oleg Borisov; Jia Jin Kee; Lindsay N Carpp; Terri Wrin; Suqin Cai; Marcella Sarzotti-Kelsoe; Charlene McDanal; Amanda Eaton; Rolando Pajon; John Hural; Christine M Posavad; Katherine Gill; Shelly Karuna; Lawrence Corey; M Juliana McElrath; Peter B Gilbert; Christos J Petropoulos; David C Montefiori
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

5.  Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation.

Authors:  Yunda Huang; Oleg Borisov; Jia Jin Kee; Lindsay N Carpp; Terri Wrin; Suqin Cai; Marcella Sarzotti-Kelsoe; Charlene McDanal; Amanda Eaton; Rolando Pajon; John Hural; Christine M Posavad; Katherine Gill; Shelly Karuna; Lawrence Corey; M Juliana McElrath; Peter B Gilbert; Christos J Petropoulos; David C Montefiori
Journal:  Res Sq       Date:  2021-09-02

6.  Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation.

Authors:  Yunda Huang; Oleg Borisov; Jia Jin Kee; Lindsay N Carpp; Terri Wrin; Suqin Cai; Marcella Sarzotti-Kelsoe; Charlene McDanal; Amanda Eaton; Rolando Pajon; John Hural; Christine M Posavad; Katherine Gill; Shelly Karuna; Lawrence Corey; M Juliana McElrath; Peter B Gilbert; Christos J Petropoulos; David C Montefiori
Journal:  medRxiv       Date:  2021-09-14

Review 7.  Comparability and reproducibility of biomedical data.

Authors:  Yunda Huang; Raphael Gottardo
Journal:  Brief Bioinform       Date:  2012-11-27       Impact factor: 11.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.